Tanvex Biopharma USA, Inc

Tanvex BioPharma, Inc. is a vertically integrated biopharmaceutical company dedicated to developing and manufacturing safe, effective, and affordable biologics and biosimilars.

Founded by Dr. Allen Chao, the visionary behind Watson Pharmaceuticals, Tanvex leverages decades of experience to address the complexities of biopharmaceutical production. The company operates state-of-the-art facilities in San Diego, USA, and Taiwan, enabling comprehensive in-house processes from research and development to commercial-scale manufacturing. This vertical integration ensures high-quality and consistent products, allowing Tanvex to respond swiftly to evolving market and regulatory demands.

Key Products and Services:

• Biosimilars Development: Tanvex focuses on creating biosimilars targeting conditions such as neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis, aiming to provide cost-effective therapeutic options.
• Contract Development and Manufacturing (CDMO) Services: Operating under the Bora Biologics brand, Tanvex offers end-to-end solutions, including analytical development, process optimization, GMP manufacturing, and regulatory support, to biopharma clients worldwide.
• Vertical Integration: The company's in-house capabilities encompass cell-line development, process development, and large-scale manufacturing, ensuring product quality and operational efficiency.

Tanvex BioPharma is committed to advancing biopharmaceutical innovation and accessibility, striving to deliver life-saving therapies to patients globally while maintaining high standards of quality and affordability.